Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BioMarin Pharmaceutical
Age
7–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient consent
Patient must have successfully completed study ASB-03-05, including having received at least 20 of 24 scheduled weekly infusions and having missed no more then two consecutive infusions
If female of childbearing potential, patient must have a negative pregnancy test
You may not be if
Pregnant or lactating patient
Patient has received an investigational drug within 30 days prior to study enrollment
Patient is unwilling or unable to travel to the primary site for periodic assessments
Clareo Health | Study of rhASB in Patients With Mucopolysaccharidosis VI
